Advanced Proteome Therapeutics Corp (APC)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Advanced Proteome Therapeutics Corp (APC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013544
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Advanced Proteome Therapeutics Corporation (APC) is a biopharmaceutical company that focuses on the development of anticancer therapeutics that capitalizes on the properties of a natural human protein. It creates, develops and commercializes novel therapies. The company is advancing a site-specific protein modification technology platform for the development of proprietary human protein pharmaceuticals with enhanced therapeutic properties and greater affinity for the target cancer cells and tumors. The patent pending technology combines anti-cancer therapies in a single agent to directly target cancerous tumors and avoid destroying normal cells. The company carries out its operations through its subsidiary; Advanced Proteome Therapeutics Inc. APC is headquartered in Boston, Massachusetts, the US.

Advanced Proteome Therapeutics Corp (APC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Advanced Proteome Therapeutics Raises US$0.04 Million In Venture Financing 12
Partnerships 13
Advanced Proteome Therapeutics Expands Agreement with National Research Council of Canada 13
Advanced Proteome Therapeutics Enters into Agreement with Heidelberg Pharma 14
Licensing Agreements 15
Glenmark Pharma Enters into Licensing Agreement with Advanced Proteome Therapeutics 15
Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 16
Equity Offering 17
Advanced Proteome Therapeutics to Raise USD0.4 Million in Private Placement of Shares 17
Advanced Proteome Therapeutics Raises USD0.3 Million in Rights Offering of Units 18
Advanced Proteome Therapeutics Raises USD0.1 Million in First Tranche of Private Placement of Units 19
Advanced Proteome Therapeutics to Raise USD0.2 Million in Private Placement of Shares 20
Advanced Proteome Therapeutics Raises USD0.2 Million in Private Placement of Units 21
Advanced Proteome Therapeutics Raises USD0.4 Million in Private Placement of Shares upon Exercise of Warrants 23
Advanced Proteome Therapeutics Raises USD0.6 Million in Private Placement of Units 24
Advanced Proteome Therapeutics Raises USD0.24 Million in Private Placement of Units 25
Advanced Proteome Therapeutics Raises USD0.17 Million in Private Placement of Units 26
Advanced Proteome Therapeutics Completes Private Placement Of Shares For US$0.2 Million 27
Advanced Proteome Therapeutics Completes Private Placement Of Units For US$0.7 Million 28
Advanced Proteome Therapeutics Completes Private Placement Of Units For US$0.3 Million 29
Advanced Proteome Therapeutics Completes First Tranche Of Private Placement Of Units For US$0.2 Million 30
Advanced Proteome Therapeutics Corp – Key Competitors 31
Advanced Proteome Therapeutics Corp – Key Employees 32
Advanced Proteome Therapeutics Corp – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Corporate Communications 34
Jul 31, 2017: Advanced Proteome Therapeutics Announces 2017 AGM Results and Corporate Update 34
Feb 06, 2017: Advanced Proteome Therapeutics Announces the Appointment of Dr. Randal Chase to Its Executive Leadership Team 35
Government and Public Interest 36
Apr 15, 2016: Advanced Proteome Therapeutics Embarks Upon a Major Antibody Initiative 36
Product News 37
Nov 29, 2016: APC Invents Quantitative Method for Assessing Pattern of Antibody Labeling Impacting the Emerging, Rapidly Growing Market for Antibody-Drug Conjugates (ADC) 37
Other Significant Developments 38
Jul 18, 2016: Advanced Proteome Therapeutics Formulates Strategic Plan Featuring Novel Antibody Program 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Advanced Proteome Therapeutics Corp, Deals By Therapy Area, 2011 to YTD 2017 9
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Advanced Proteome Therapeutics Raises US$0.04 Million In Venture Financing 12
Advanced Proteome Therapeutics Expands Agreement with National Research Council of Canada 13
Advanced Proteome Therapeutics Enters into Agreement with Heidelberg Pharma 14
Glenmark Pharma Enters into Licensing Agreement with Advanced Proteome Therapeutics 15
Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 16
Advanced Proteome Therapeutics to Raise USD0.4 Million in Private Placement of Shares 17
Advanced Proteome Therapeutics Raises USD0.3 Million in Rights Offering of Units 18
Advanced Proteome Therapeutics Raises USD0.1 Million in First Tranche of Private Placement of Units 19
Advanced Proteome Therapeutics to Raise USD0.2 Million in Private Placement of Shares 20
Advanced Proteome Therapeutics Raises USD0.2 Million in Private Placement of Units 21
Advanced Proteome Therapeutics Raises USD0.4 Million in Private Placement of Shares upon Exercise of Warrants 23
Advanced Proteome Therapeutics Raises USD0.6 Million in Private Placement of Units 24
Advanced Proteome Therapeutics Raises USD0.24 Million in Private Placement of Units 25
Advanced Proteome Therapeutics Raises USD0.17 Million in Private Placement of Units 26
Advanced Proteome Therapeutics Completes Private Placement Of Shares For US$0.2 Million 27
Advanced Proteome Therapeutics Completes Private Placement Of Units For US$0.7 Million 28
Advanced Proteome Therapeutics Completes Private Placement Of Units For US$0.3 Million 29
Advanced Proteome Therapeutics Completes First Tranche Of Private Placement Of Units For US$0.2 Million 30
Advanced Proteome Therapeutics Corp, Key Competitors 31
Advanced Proteome Therapeutics Corp, Key Employees 32
Advanced Proteome Therapeutics Corp, Subsidiaries 33

★海外企業調査レポート[Advanced Proteome Therapeutics Corp (APC)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cerus Corp (CERS)-医療機器分野:企業M&A・提携分析
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • Innoviva Inc (INVA):企業の財務・戦略的SWOT分析
    Innoviva Inc (INVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • The Boston Consulting Group:企業の戦略的SWOT分析
    The Boston Consulting Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Michels Corp:企業の戦略・SWOT・財務情報
    Michels Corp - Strategy, SWOT and Corporate Finance Report Summary Michels Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Molex LLC:医療機器:M&Aディール及び事業提携情報
    Summary Molex LLC (Molex), a subsidiary of Koch Industries, is a US-based manufacturer of electronic components. The company principally focuses on manufacturing and sale of electronic, electrical and fiber optic interconnection systems. Molex's product portfolio includes switches, integrated produc …
  • Michelin SCA (ML):企業の財務・戦略的SWOT分析
    Michelin SCA (ML) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • VTT Technical Research Centre of Finland-製薬・医療分野:企業M&A・提携分析
    Summary VTT Technical Research Centre of Finland (VTT) is a research and technology center that offers development services. The center provides research services on bioeconomy and circular economy, health and wellbeing, digital society, low carbon energy, smart industry, sustainable and smart city, …
  • The Wharf (Holdings) Limited
    The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Teledyne Technologies Incorporated:企業の戦略・SWOT・財務情報
    Teledyne Technologies Incorporated - Strategy, SWOT and Corporate Finance Report Summary Teledyne Technologies Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • La Jolla Institute for Allergy & Immunology:製薬・医療:M&Aディール及び事業提携情報
    Summary La Jolla Institute for Allergy & Immunology (LIAI) is a biomedical research institute that offers solutions for infectious agents and cancers. The institute provides research on prevention, treatment, and cure of immune system diseases. Its activities include disease research on allergy and …
  • PeptiDream Inc (4587):製薬・医療:M&Aディール及び事業提携情報
    Summary PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptide-drug conjugate therapeutics. The company develops peptide discovery platform system (PDPS), a peptide generation and selection platform that helps to produ …
  • Korea East-West Power Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Korea East-West Power Co., Ltd. (EWP), subsidiary of Korea Electric Power Corporation, is a state-owned electric utility that generates and supplies electricity. It produces electricity from various sources including coal, oil, liquefied natural gas, mini hydro, and renewable sources such as …
  • Panera Bread Company:企業の戦略的SWOT分析
    Panera Bread Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Mediacom Communications Corporation:企業の戦略的SWOT分析
    Mediacom Communications Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Egmont International Holding AS:企業の戦略的SWOT分析
    Egmont International Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Avantec Vascular Corp:企業の製品パイプライン分析2018
    Summary Avantec Vascular Corp (Avantec Vascular), a subsidiary of Goodman Co Ltd, is a medical device company that develops cardiovascular interventional and peripheral vascular devices. The company's products comprise balloon catheter, aspiration catheter, device delivery system, micro catheter, gu …
  • Luxoft Holding Inc:企業の戦略・SWOT・財務情報
    Luxoft Holding Inc - Strategy, SWOT and Corporate Finance Report Summary Luxoft Holding Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Burwill Holdings Limited:企業のM&A・事業提携・投資動向
    Burwill Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Burwill Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Texas Health Resources:企業の戦略的SWOT分析
    Texas Health Resources - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Danaher Corp (DHR):医療機器:M&Aディール及び事業提携情報
    Summary Danaher Corp (Danaher) is a medical technology company which designs, manufactures and markets medical, professional, commercial and industrial products and services. It offers a wide range of testing instruments, communications solutions, water quality systems, medical diagnostics solutions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆